Profile: Cdr Therapeutics Inc. develops small molecules that mimic binding regions or complementarity-determining regions of immunoglobulin proteins such as monoclonal antibodies. We offer several compounds to target cancer, autoimmune diseases, inflammatory skin diseases, transplant rejection and corneal injury or surgery. We supplies drugs to treat cancer, autoimmune diseases, transplant rejection, eye injury & skin diseases.